ABOUT MITOX
The Nuffield Department of Women's & Reproductive Health invites you to MitOX 2020 on Thursday 3rd and Friday 4th December 2020. It's our annual meeting packed with short talks and posters on cancer metabolism, neuroscience, diabetes, mitochondrial disorders and general mitochondrial biology. This two day virtual conference is ideal for researchers with an interest in mitochondria from academia and pharma. It will include a range of short talks and posters on cancer metabolism, neuroscience, diabetes, mitochondrial disorders and general mitochondrial biology.
HOW TO BOOK
Book online here
The last booking date for this event is Sunday 29th November 2020. For all conference enquiries, please contact ndwrhmitox@wrh.ox.ac.uk
SPEAKERS
|
THURSDAY 3RD DECEMBER |
|
|
|
Karl Morten |
Welcome |
University of Oxford |
|
Heart and Endothelium |
|
|
|
Mark Crabtree |
Citrate and itaconate in inflammatory activation in cardiovascular medicine. |
University of Oxford |
| Carolyn Carr |
Can we model the diabetic human heart in a dish using iPSC-derived cardiomyocytes? |
University of Oxford |
| Emy Bosseboeuf |
Neuropilin-1 controls endothelial homeostasis by regulating mitochondrial function and iron-dependent oxidative stress via ABCB8 |
Queen Mary, London |
| Kerstin Timm |
AMPK activation by AICAR prevents doxorubicin-induced heart failure in rats |
University of Oxford |
| Mitophagy and Mitochondrial Biology |
|
|
| Nicholas T Ktistakis | The dynamics of mitochondrial autophagy (Pollard Lecture) | Babraham Institute, University of Cambridge |
|
Jo Poulton |
Mitophagy in mitochondrial diseases. |
University of Oxford |
|
Jo Howson |
MtDNA and diabetes. |
University of Oxford |
|
Ana Lima |
Differences in mitochondrial activity trigger cell competition during early mouse development |
Imperial College, London |
|
FRIDAY 4TH DECEMBER |
|
|
|
Geoff Higgins |
Repurposing atovaquone as a novel tumour hypoxia modifier: results from the ATOM clinical trial |
University of Oxford |
|
Tim Sparey |
Impact of Mitochondrial Targeting Antibiotics on Mitochondrial Function and Proliferation of Cancer Cells. |
Novintum |
|
Jessica Whitburn |
Metabolic profiling of prostate cancer cells within skeletal microenvironments identifies G6PD as a key mediator of bone-metastatic prostate cancer growth and survival. |
University of Oxford |
|
Monika Golinska |
Metabolic survival mechanisms and the peroxisome-mitochondria link in HIF deficient cells |
University of Cambridge |
|
Mitochondrial Medicine |
|
|
|
James Mccullagh |
IDH mutations in cancer. |
University of Oxford |
|
Karl Morten |
Plasma Metabolomics in ME/CFS: a tale of two cohorts. |
University of Oxford |
|
Bhupesh Prusty |
Mitochondrial architecture decides the niche for pathogenic survival. |
University of Wuerzburg, Germany |
|
Melis Karabulutoglu |
Mechanisms of radiation leukaemogenesis, characterisation of haematopoietic stem cells and modulation of risk |
University of Oxford |